Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 243

1.

Clinical practice guidelines for the management of atopic dermatitis 2018.

Katoh N, Ohya Y, Ikeda M, Ebihara T, Katayama I, Saeki H, Shimojo N, Tanaka A, Nakahara T, Nagao M, Hide M, Fujita Y, Fujisawa T, Futamura M, Masuda K, Murota H, Yamamoto-Hanada K.

J Dermatol. 2019 Oct 9. doi: 10.1111/1346-8138.15090. [Epub ahead of print]

PMID:
31599013
2.

Efficacy and safety of dupilumab in Japanese adults with moderate-to-severe atopic dermatitis: a subanalysis of three clinical trials.

Katoh N, Kataoka Y, Saeki H, Hide M, Kabashima K, Etoh T, Igarashi A, Imafuku S, Kawashima M, Ohtsuki M, Fujita H, Arima K, Takagi H, Chen Z, Shumel B, Ardeleanu M.

Br J Dermatol. 2019 Sep 28. doi: 10.1111/bjd.18565. [Epub ahead of print]

PMID:
31564057
3.

High histamine concentrations in human sweat in association with type I allergy to the semi-purified sweat antigen.

Takahagi S, Okamoto M, Ishii K, Tanaka A, Yanase Y, Hide M.

Allergol Int. 2019 Sep 20. pii: S1323-8930(19)30140-6. doi: 10.1016/j.alit.2019.08.011. [Epub ahead of print] No abstract available.

4.

A case of high altitude cutaneous leishmaniasis in a non-endemic region in Nepal.

Bastola A, Shrestha M, Lamsal M, Shrestha S, Prajapati S, Adhikari A, Gupta BP, Hide M, Devkota L, Chalise BS, Pandey K, Manandhar KD.

Parasitol Int. 2019 Sep 11:101991. doi: 10.1016/j.parint.2019.101991. [Epub ahead of print]

PMID:
31520692
5.

Spread of NDM-5 and OXA-181 carbapenemase-producing Escherichia coli in Chad.

Ouchar Mahamat O, Lounnas M, Hide M, Tidjani A, Benavides J, Diack A, Somasse C, Gamougam K, Carrière C, Decré D, Bañuls AL, Jean-Pierre H, Dumont Y, Compain F, Godreuil S.

Antimicrob Agents Chemother. 2019 Aug 12. pii: AAC.00646-19. doi: 10.1128/AAC.00646-19. [Epub ahead of print]

PMID:
31405861
6.

Reduction of serum thymus and activation-regulated chemokine after short-term intensive therapy may predict better prognosis of moderate to severe atopic dermatitis.

Saito R, Tanaka A, Hiragun T, Iwamoto K, Takahagi S, Takahashi M, Hide M.

J Dermatol. 2019 Aug 2. doi: 10.1111/1346-8138.15036. [Epub ahead of print] No abstract available.

PMID:
31376173
7.

Dupilumab shows long-term safety and efficacy in moderate-to-severe atopic dermatitis patients enrolled in a phase 3 open-label extension study.

Deleuran M, Thaçi D, Beck LA, de Bruin-Weller M, Blauvelt A, Forman S, Bissonnette R, Reich K, Soong W, Hussain I, Foley P, Hide M, Bouaziz JD, Gelfand JM, Sher L, Schuttelaar MLA, Wang C, Chen Z, Akinlade B, Gadkari A, Eckert L, Davis JD, Rajadhyaksha M, Staudinger H, Graham NMH, Pirozzi G, Ardeleanu M.

J Am Acad Dermatol. 2019 Jul 30. pii: S0190-9622(19)32465-X. doi: 10.1016/j.jaad.2019.07.074. [Epub ahead of print]

8.

HLA-DQ and RBFOX1 as susceptibility genes for an outbreak of hydrolyzed wheat allergy.

Noguchi E, Akiyama M, Yagami A, Hirota T, Okada Y, Kato Z, Kishikawa R, Fukutomi Y, Hide M, Morita E, Aihara M, Hiragun M, Chinuki Y, Okabe T, Ito A, Adachi A, Fukunaga A, Kubota Y, Aoki T, Aoki Y, Nishioka K, Adachi T, Kanazawa N, Miyazawa H, Sakai H, Kozuka T, Kitamura H, Hashizume H, Kanegane C, Masuda K, Sugiyama K, Tokuda R, Furuta J, Higashimoto I, Kato A, Seishima M, Tajiri A, Tomura A, Taniguchi H, Kojima H, Tanaka H, Sakai A, Morii W, Nakamura M, Kamatani Y, Takahashi A, Kubo M, Tamari M, Saito H, Matsunaga K.

J Allergy Clin Immunol. 2019 Jul 10. pii: S0091-6749(19)30901-7. doi: 10.1016/j.jaci.2019.06.034. [Epub ahead of print]

PMID:
31301374
9.

Decreased intracellular histamine concentration and basophil activation in anaphylaxis.

Yamaga S, Yanase Y, Ishii K, Ohshimo S, Shime N, Hide M.

Allergol Int. 2019 Jun 24. pii: S1323-8930(19)30070-X. doi: 10.1016/j.alit.2019.05.009. [Epub ahead of print]

10.
11.

Successful treatment of refractory dermal pain with etizolam and clonazepam in a patient with acquired idiopathic generalized anhidrosis.

Okamoto M, Takahagi S, Kamegashira A, Yanase Y, Hide M.

J Dermatol. 2019 Oct;46(10):e351-e353. doi: 10.1111/1346-8138.14921. Epub 2019 May 15. No abstract available.

PMID:
31090227
12.

Development of SPR Imaging-Impedance Sensor for Multi-Parametric Living Cell Analysis.

Yanase Y, Yoshizaki K, Kimura K, Kawaguchi T, Hide M, Uno S.

Sensors (Basel). 2019 May 3;19(9). pii: E2067. doi: 10.3390/s19092067.

13.

Staphylococcus aureus in atopic dermatitis: Strain-specific cell wall proteins and skin immunity.

Iwamoto K, Moriwaki M, Miyake R, Hide M.

Allergol Int. 2019 Jul;68(3):309-315. doi: 10.1016/j.alit.2019.02.006. Epub 2019 Mar 14. Review.

14.

High prevalence and characterization of extended-spectrum ß-lactamase producing Enterobacteriaceae in Chadian hospitals.

Ouchar Mahamat O, Lounnas M, Hide M, Dumont Y, Tidjani A, Kamougam K, Abderrahmane M, Benavides J, Solassol J, Bañuls AL, Jean-Pierre H, Carrière C, Godreuil S.

BMC Infect Dis. 2019 Feb 28;19(1):205. doi: 10.1186/s12879-019-3838-1.

15.

[POINTS OF REVISE IN THE INTERNATIONAL WAO/EAACI GUIDELINE FOR THE MANAGEMENT OF HEREDITARY ANGIOEDEMA-THE 2017 REVISION AND UPDATE].

Hide M.

Arerugi. 2019;68(1):16-19. doi: 10.15036/arerugi.68.16. Japanese. No abstract available.

PMID:
30787237
16.

Activation of Human Peripheral Basophils in Response to High IgE Antibody Concentrations without Antigens.

Yanase Y, Matsuo Y, Kawaguchi T, Ishii K, Tanaka A, Iwamoto K, Takahagi S, Hide M.

Int J Mol Sci. 2018 Dec 22;20(1). pii: E45. doi: 10.3390/ijms20010045.

17.

[JAPANESE GUIDELINES FOR DIAGNOSIS AND TREATMENT OF URTICARIA 2018].

Hide M.

Arerugi. 2018;67(10):1394-1398. doi: 10.15036/arerugi.67.1394. Japanese. No abstract available.

PMID:
30541974
18.

Case of malignant melanoma responding to dacarbazine following nivolumab.

Saito R, Kawai M, Hirakawa K, Tanaka M, Takahagi S, Hide M.

Dermatol Ther. 2019 Mar;32(2):e12791. doi: 10.1111/dth.12791. Epub 2018 Dec 12. No abstract available.

PMID:
30488521
19.

Staphylococcus aureus from atopic dermatitis skin accumulates in the lysosomes of keratinocytes with induction of IL-1α secretion via TLR9.

Moriwaki M, Iwamoto K, Niitsu Y, Matsushima A, Yanase Y, Hisatsune J, Sugai M, Hide M.

Allergy. 2019 Mar;74(3):560-571. doi: 10.1111/all.13622. Epub 2018 Nov 12.

PMID:
30269350
20.

Case of anaphylaxis to lansoprazole confirmed by histamine release test and oral provocation test.

Moriwaki M, Iwamoto K, Ishii K, Takahagi S, Hide M.

J Dermatol. 2019 Apr;46(4):e124-e125. doi: 10.1111/1346-8138.14628. Epub 2018 Aug 27. No abstract available.

PMID:
30152079
21.

Sweat allergy.

Takahagi S, Tanaka A, Hide M.

Allergol Int. 2018 Oct;67(4):435-441. doi: 10.1016/j.alit.2018.07.002. Epub 2018 Jul 31. Review.

22.
23.

Neuromedin U directly induces degranulation of skin mast cells, presumably via MRGPRX2.

Matsuo Y, Yanase Y, Irifuku R, Takahagi S, Mihara S, Ishii K, Kawaguchi T, Tanaka A, Iwamoto K, Watanuki H, Furuta K, Tanaka S, Inoue A, Aoki J, Hide M.

Allergy. 2018 Nov;73(11):2256-2260. doi: 10.1111/all.13555. Epub 2018 Jul 29. No abstract available.

PMID:
29987892
24.

Impact of chronic urticaria on quality of life and work in Japan: Results of a real-world study.

Itakura A, Tani Y, Kaneko N, Hide M.

J Dermatol. 2018 Aug;45(8):963-970. doi: 10.1111/1346-8138.14502. Epub 2018 Jun 13.

25.

Two cases of conjunctival squamous cell carcinoma in the anophthalmic socket after treatment of retinoblastoma.

Oka S, Tsuboi S, Morita C, Umeda N, Kawai M, Itakura H, Hide M.

J Dermatol. 2018 Dec;45(12):e346-e347. doi: 10.1111/1346-8138.14490. Epub 2018 Jun 4. No abstract available.

PMID:
29863813
26.

Evaluation of Risk of Injury by Extravasation of Hyperosmolar and Vasopressor Agents in a Rat Model.

Shibata Y, Sagara Y, Yokooji T, Taogoshi T, Tanaka M, Hide M, Matsuo H.

Biol Pharm Bull. 2018;41(6):951-956. doi: 10.1248/bpb.b18-00105.

27.

The role of adenosine for IgE receptor-dependent degranulation of human peripheral basophils and skin mast cells.

Matsuo Y, Yanase Y, Irifuku R, Ishii K, Kawaguchi T, Takahagi S, Hide I, Hide M.

Allergol Int. 2018 Oct;67(4):524-526. doi: 10.1016/j.alit.2018.03.007. Epub 2018 Apr 25. No abstract available.

28.

[EFFICACY, PHARMACOKINETICS, AND SAFETY OF ICATIBANT FOR THE TREATMENT OF JAPANESE PATIENTS WITH AN ACUTE ATTACK OF HEREDITARY ANGIOEDEMA: A PHASE 3 OPEN-LABEL STUDY].

Hide M, Fukunaga A, Maehara J, Eto K, Hao J, Vardi M, Nomoto Y.

Arerugi. 2018;67(2):139-147. doi: 10.15036/arerugi.67.139. Japanese.

PMID:
29553114
29.

A case of Kaposi varicelliform eruption progressing to herpes simplex virus hepatitis in an immunocompetent patient.

Okamoto M, Takahagi S, Tanaka A, Ogawa A, Nobuki H, Hide M.

Clin Exp Dermatol. 2018 Jul;43(5):636-638. doi: 10.1111/ced.13405. Epub 2018 Feb 15. No abstract available.

PMID:
29446473
30.

Rapid exacerbation of malignant melanoma during short-term discontinuation of vemurafenib.

Saito R, Iwamoto K, Tanaka Y, Kawai M, Hide M.

Australas J Dermatol. 2018 Nov;59(4):e274-e276. doi: 10.1111/ajd.12784. Epub 2018 Jan 29. No abstract available.

PMID:
29380358
31.

The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria.

Zuberbier T, Aberer W, Asero R, Abdul Latiff AH, Baker D, Ballmer-Weber B, Bernstein JA, Bindslev-Jensen C, Brzoza Z, Buense Bedrikow R, Canonica GW, Church MK, Craig T, Danilycheva IV, Dressler C, Ensina LF, Giménez-Arnau A, Godse K, Gonçalo M, Grattan C, Hebert J, Hide M, Kaplan A, Kapp A, Katelaris CH, Kocatürk E, Kulthanan K, Larenas-Linnemann D, Leslie TA, Magerl M, Mathelier-Fusade P, Meshkova RY, Metz M, Nast A, Nettis E, Oude-Elberink H, Rosumeck S, Saini SS, Sánchez-Borges M, Schmid-Grendelmeier P, Staubach P, Sussman G, Toubi E, Vena GA, Vestergaard C, Wedi B, Werner RN, Zhao Z, Maurer M; Endorsed by the following societies: AAAAI, AAD, AAIITO, ACAAI, AEDV, APAAACI, ASBAI, ASCIA, BAD, BSACI, CDA, CMICA, CSACI, DDG, DDS, DGAKI, DSA, DST, EAACI, EIAS, EDF, EMBRN, ESCD, GA²LEN, IAACI, IADVL, JDA, NVvA, MSAI, ÖGDV, PSA, RAACI, SBD, SFD, SGAI, SGDV, SIAAIC, SIDeMaST, SPDV, TSD, UNBB, UNEV and WAO.

Allergy. 2018 Jul;73(7):1393-1414. doi: 10.1111/all.13397.

PMID:
29336054
32.

The international WAO/EAACI guideline for the management of hereditary angioedema-The 2017 revision and update.

Maurer M, Magerl M, Ansotegui I, Aygören-Pürsün E, Betschel S, Bork K, Bowen T, Balle Boysen H, Farkas H, Grumach AS, Hide M, Katelaris C, Lockey R, Longhurst H, Lumry WR, Martinez-Saguer I, Moldovan D, Nast A, Pawankar R, Potter P, Riedl M, Ritchie B, Rosenwasser L, Sánchez-Borges M, Zhi Y, Zuraw B, Craig T.

Allergy. 2018 Aug;73(8):1575-1596. doi: 10.1111/all.13384. Epub 2018 Mar 12.

PMID:
29318628
33.

A unique clinical phenotype of a patient bearing a newly identified deletion mutation in the PSENEN gene along with the pathogenic serum desmoglein-1 antibody.

Kan T, Takahagi S, Shindo H, Tanaka A, Kawai M, Hide M.

Clin Exp Dermatol. 2018 Apr;43(3):329-332. doi: 10.1111/ced.13326. Epub 2018 Jan 4. No abstract available.

PMID:
29314153
34.

Efficacy and safety of omalizumab for the treatment of refractory chronic spontaneous urticaria in Japanese patients: Subgroup analysis of the phase 3 POLARIS study.

Hide M, Igarashi A, Yagami A, Chinuki Y, Inomata N, Fukunaga A, Kaiser G, Wang J, Matsushima S, Greenberg S, Khalil S.

Allergol Int. 2018 Apr;67(2):243-252. doi: 10.1016/j.alit.2017.10.001. Epub 2017 Nov 1.

35.

Impedance-Based Living Cell Analysis for Clinical Diagnosis of Type I Allergy.

Irifuku R, Yanase Y, Kawaguchi T, Ishii K, Takahagi S, Hide M.

Sensors (Basel). 2017 Oct 31;17(11). pii: E2503. doi: 10.3390/s17112503.

36.

Presymptomatic genetic diagnosis of two siblings with hereditary angioedema, presenting with unusual normal levels of serum C4.

Kasami S, Sowa-Osako J, Fukai K, Tokimasa S, Kaga SI, Saito R, Tanaka A, Hide M, Tsuruta D.

J Dermatol. 2018 Feb;45(2):e31-32. doi: 10.1111/1346-8138.14103. Epub 2017 Oct 23. No abstract available.

PMID:
29058329
37.

Chronic spontaneous urticaria and the extrinsic coagulation system.

Yanase Y, Takahagi S, Hide M.

Allergol Int. 2018 Apr;67(2):191-194. doi: 10.1016/j.alit.2017.09.003. Epub 2017 Oct 6. Review.

38.

Injury due to extravasation of thiopental and propofol: Risks/effects of local cooling/warming in rats.

Shibata Y, Yokooji T, Itamura R, Sagara Y, Taogoshi T, Ogawa K, Tanaka M, Hide M, Kihira K, Matsuo H.

Biochem Biophys Rep. 2016 Sep 19;8:207-211. doi: 10.1016/j.bbrep.2016.09.005. eCollection 2016 Dec.

39.

Histamine and Toll-like receptor ligands synergistically induce endothelial cell gap formation by the extrinsic coagulating pathway.

Yanase Y, Morioke S, Iwamoto K, Takahagi S, Uchida K, Kawaguchi T, Ishii K, Hide I, Hide M.

J Allergy Clin Immunol. 2018 Mar;141(3):1115-1118.e7. doi: 10.1016/j.jaci.2017.07.026. Epub 2017 Aug 30. No abstract available.

PMID:
28859973
40.

Staphylococcus aureus from atopic dermatitis skin alters cytokine production triggered by monocyte-derived Langerhans cell.

Iwamoto K, Moriwaki M, Niitsu Y, Saino M, Takahagi S, Hisatsune J, Sugai M, Hide M.

J Dermatol Sci. 2017 Dec;88(3):271-279. doi: 10.1016/j.jdermsci.2017.08.001. Epub 2017 Aug 5.

PMID:
28822698
41.

Case of cholinergic urticaria accompanied by anaphylaxis.

Iijima S, Kojo K, Takayama N, Hiragun M, Kan T, Hide M.

J Dermatol. 2017 Nov;44(11):1291-1294. doi: 10.1111/1346-8138.13951. Epub 2017 Jun 30.

PMID:
28665007
42.

Different hypersensitivities against homologous proteins of MGL_1304 in patients with atopic dermatitis.

Kohsaka T, Hiragun T, Ishii K, Hiragun M, Kamegashira A, Hide M.

Allergol Int. 2018 Jan;67(1):103-108. doi: 10.1016/j.alit.2017.05.009. Epub 2017 Jun 24.

43.

The first nationwide surveillance of antibacterial susceptibility patterns of pathogens isolated from skin and soft-tissue infections in dermatology departments in Japan.

Watanabe S, Ohnishi T, Yuasa A, Kiyota H, Iwata S, Kaku M, Watanabe A, Sato J, Hanaki H, Manabe M, Suzuki T, Otsuka F, Aihara M, Iozumi K, Tamaki T, Funada Y, Shinozaki M, Kobayashi M, Okuda M, Kikyo G, Kikuchi K, Okada Y, Takeshima M, Kaneko O, Ogawa N, Ito R, Okuyama R, Shimada S, Shimizu T, Hatta N, Manabu M, Tsutsui K, Tanaka T, Miyachi Y, Asada H, Furukawa F, Kurokawa I, Iwatsuki K, Hide M, Muto M, Yamamoto O, Niihara H, Takagaki K, Kubota Y, Sayama K, Sano S, Furue M, Kanekura T.

J Infect Chemother. 2017 Aug;23(8):503-511. doi: 10.1016/j.jiac.2017.05.006. Epub 2017 Jun 20.

PMID:
28645883
44.

Outbreak of immediate-type hydrolyzed wheat protein allergy due to a facial soap in Japan.

Yagami A, Aihara M, Ikezawa Z, Hide M, Kishikawa R, Morita E, Chinuki Y, Fukutomi Y, Urisu A, Fukushima A, Itagaki Y, Sugiura SI, Tanaka H, Teshima R, Kato Z, Noguchi E, Nakamura M, Saito H, Matsunaga K.

J Allergy Clin Immunol. 2017 Sep;140(3):879-881.e7. doi: 10.1016/j.jaci.2017.03.019. Epub 2017 Jun 17. No abstract available.

45.

Contact urticaria syndrome with IgE antibody against a cefotiam-unique structure, evoked by nonapparent exposure to cefotiam.

Takahagi S, Tanaka A, Iwamoto K, Ishii K, Hide M.

Clin Exp Dermatol. 2017 Jul;42(5):527-531. doi: 10.1111/ced.13126. Epub 2017 May 22.

PMID:
28543395
46.

Evaluation of skin perfusion pressure to assess refractory foot ulcers.

Kawai M, Mihara S, Takahagi S, Iwamoto K, Hiragun T, Hide M.

J Wound Care. 2017 May 2;26(5):267-270. doi: 10.12968/jowc.2017.26.5.267.

PMID:
28475443
47.

Sweat allergy: Extrinsic or intrinsic?

Hiragun T, Hiragun M, Ishii K, Kan T, Hide M.

J Dermatol Sci. 2017 Jul;87(1):3-9. doi: 10.1016/j.jdermsci.2017.03.002. Epub 2017 Mar 9. Review.

PMID:
28416076
48.

Efficacy and safety of omalizumab in Japanese and Korean patients with refractory chronic spontaneous urticaria.

Hide M, Park HS, Igarashi A, Ye YM, Kim TB, Yagami A, Roh J, Lee JH, Chinuki Y, Youn SW, Lee SK, Inomata N, Choi JH, Fukunaga A, Wang J, Matsushima S, Greenberg S, Khalil S.

J Dermatol Sci. 2017 Jul;87(1):70-78. doi: 10.1016/j.jdermsci.2017.03.009. Epub 2017 Mar 21.

49.

Prognosis of adult-onset clinically amyopathic dermatomyositis treated with only topical therapy.

Matsuo Y, Mihara S, Tanaka A, Kawai M, Hide M.

J Dermatol. 2017 Jul;44(7):e178-e179. doi: 10.1111/1346-8138.13822. Epub 2017 Mar 7. No abstract available.

PMID:
28266052
50.

JAPANESE GUIDELINES FOR DIAGNOSIS AND TREATMENT OF URTICARIA.

Hiragun T, Hide M.

Arerugi. 2017;66(1):23-26. doi: 10.15036/arerugi.66.23. Japanese. No abstract available.

PMID:
28216532

Supplemental Content

Support Center